Address
Registered office address 4 Dorset Road, London, England, SE9 4QT
Work Hours
Monday to Friday: 7AM - 10PM
Weekend: 9AM - 8PM
Email Us
enquiries@vantixbio.co.uk.
Address
Registered office address 4 Dorset Road, London, England, SE9 4QT
Work Hours
Monday to Friday: 7AM - 10PM
Weekend: 9AM - 8PM
Email Us
enquiries@vantixbio.co.uk.

Price range: £83.00 through £100.00
A research-use blend formulation of BPC-157, GHK-Cu, TB-500 and KPV in a single lyophilised vial.
Everything researchers commonly contact us about, explained clearly in one place.
Yes. Every batch is independently verified through Janoshik Analytical HPLC testing.
All products supplied are analysed by Janoshik Analytical, an independent Czech laboratory specialising in peptide analysis. Reported purity levels consistently exceed 99%.
When a Janoshik Certificate of Analysis (COA) is available for the current batch, a printed copy is included with the order. If a report has not been issued for that batch, the verification information is published through our Purity page.
Each COA contains a unique verification key that can be validated through Janoshik’s own verification platform, allowing researchers to independently confirm the results.
We also provide guidance on how to interpret Janoshik HPLC reports for full transparency.
Follow these four preparation steps:
Use an alcohol prep wipe supplied in the package to clean the vial tops. Allow the surface to dry fully.
Using an insulin syringe, withdraw 2 mL of bacteriostatic water by inserting the needle through the rubber stopper.
Introduce the liquid gradually down the inside wall of the peptide vial. Avoid spraying directly onto the powder.
Gently swirl until completely dissolved. Do not shake. Allow approximately 30 seconds for full dissolution, then refrigerate.
The reconstitution guide inside the box lid can be used as a quick reference for future preparations.
Clean the pen tip using an alcohol wipe, then attach a fresh foil-wrapped needle securely.
Turn the dial one click, hold the pen upright, and press the dose button. A small drop appearing at the needle tip confirms the pen is primed and air has been removed.
Each dial click delivers a fixed increment based on the pen calibration. Typical resolution is 0.5–1 mg per click. The display window shows the selected amount.
Example: a 6 mg research setting may require approximately 6–12 clicks depending on calibration.
Published research protocols describe subcutaneous administration routes, including the abdomen, thigh and upper arm. Researchers generally rotate locations during study protocols.
Dispose of used needles in a sharps container. Replace the pen cap and return the pen to refrigerated storage.
Each pen provides the number of uses specified for the selected format. When empty, replace the cartridge while continuing to use the same pen body.
Research use only. Information is based on published research protocols and does not represent medical advice or instructions for human use.
Published research literature relating to KLOW Blend components describes subcutaneous administration routes, including the abdomen, thigh and upper arm in pharmacokinetic and clinical research settings.
Researchers commonly rotate administration sites to reduce repeated local tissue stress.
This information is provided only as scientific background from peer-reviewed literature. It does not provide medical guidance, dosing recommendations or instructions for human use.
Reference: Component-specific references (see individual peptide literature)
The appropriate approach is to follow the relevant research protocol.
Published research involving KLOW Blend components commonly uses staged progression, beginning with lower research levels and increasing according to predefined study timelines.
Researchers new to the blend typically review the initial phase of the protocol before progressing through later stages according to their study design.
Researchers already working with the compound can select the appropriate phase information to review expected requirements, product format and duration.
For custom research schedules, contact our team before ordering. We help researchers identify the most suitable format based on their planned study requirements.
Research use only. Information is derived from peer-reviewed research literature for scientific context only. It is not medical or human-use guidance.
| Category | Details |
|---|---|
| Compound | KLOW Blend |
| Research Category | Regenerative Research |
| Available Format | Single vial containing BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg |
| Pricing | Contact for current pricing |
| Format | Lyophilised powder in sealed vial |
| Purity | >99% HPLC verified by Janoshik Analytical |
| Intended Use | In-vitro laboratory research only. Not for human consumption |
Information below is compiled from public databases, including PubChem and UniProt, alongside peer-reviewed scientific literature. It is provided for laboratory characterisation purposes only.
| Property | Information |
|---|---|
| Compound Class | Proprietary peptide research blend |
| Molecular Formula | Blend |
| Molecular Weight | Blend |
| CAS Registry Number | Not applicable (blend) |
| Amino Acid Sequence | Refer to individual component peptide data |
| Receptor / Mechanism | Refer to individual constituent profiles |
| Reported Half-life | Refer to individual component data |
| Solubility | Lyophilised powder suitable for laboratory reconstitution with bacteriostatic water |
| Storage (Lyophilised) | 2–8°C; stable for 18+ months |
| Storage (Reconstituted) | 2–8°C; follow laboratory storage requirements |
| Research Status | Investigational research blend |
KLOW Blend is a combined peptide research formulation containing:
The blend is supplied as a freeze-dried powder intended exclusively for in-vitro laboratory research.
Descriptions of the compound are based on published scientific characterisation and do not represent claims regarding effects in humans.
KLOW Blend is supplied as a lyophilised powder in a sealed glass vial.
For laboratory preparation, add the required volume of diluent slowly along the inside wall of the vial. Gently swirl until fully dissolved. Avoid shaking or vortex mixing.
Prepared solutions should be stored at 2–8°C, protected from light, and handled according to appropriate laboratory procedures.
Use the Reconstitution Volume Calculator to determine the resulting concentration in mg/mL.
| State | Temperature | Typical Shelf Life |
|---|---|---|
| Lyophilised | 2–8°C or -20°C | Up to 24 months |
| Reconstituted | 2–8°C | Approximately 4–6 weeks |
Every KLOW Blend batch supplied undergoes independent HPLC verification by Janoshik Analytical.
Where a Janoshik report exists for the current batch, it is provided with the order and includes a unique verification key that can be authenticated through Janoshik’s records.
Reported purity consistently exceeds 99%.
Researchers studying KLOW Blend commonly examine related compounds within preclinical literature, including:
| Size | Blend |
|---|---|
| Format | Pen, Vial |
Reviews
There are no reviews yet.